Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Dennis J. Slamon; Brian Leyland-Jones; Steven Shak; Hank Fuchs; Virginia Paton; Alex Bajamonde; Thomas Fleming; Wolfgang Eiermann; Janet Wolter; Mark Pegram

doi:10.1056/nejm200103153441101

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Identifier:nobleid.org/w1/20260526/EA59CEA3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EA59CEA3.svg?ark=w1%2F20260526%2FEA59CEA3)](https://nobleid.org/work/w1/20260526/EA59CEA3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Identifier:nobleid.org/w1/20260526/EA59CEA3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EA59CEA3.svg?ark=w1%2F20260526%2FEA59CEA3)](https://nobleid.org/work/w1/20260526/EA59CEA3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work